Chloroquine
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00608 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 54 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | rheumatoid factor-positive polyarticular juvenile idiopathic arthritis | KG + DL |
| 2 | rheumatoid nodulosis | KG + DL |
| 3 | juvenile chronic polyarthritis | KG + DL |
| 4 | juvenile idiopathic arthritis | KG + DL |
| 5 | osteoarthritis | KG + DL |
| 6 | pseudoachondroplasia | KG + DL |
| 7 | Quinquaud’s folliculitis decalvans | KG + DL |
| 8 | Smouldering systemic mastocytosis | KG + DL |
| 9 | telogen effluvium | KG + DL |
| 10 | alopecia antibody deficiency | KG + DL |
| 11 | alopecia mucinosa | KG + DL |
| 12 | hereditary hypotrichosis with recurrent skin vesicles | KG + DL |
| 13 | alopecia-intellectual disability-hypergonadotropic hypogonadism syndrome | KG + DL |
| 14 | alopecia areata | KG + DL |
| 15 | lymphoadenopathic mastocytosis with eosinophilia | KG + DL |
| 16 | acromesomelic dysplasia, Hunter-Thompson type | KG + DL |
| 17 | ankylosing spondylitis | KG + DL |
| 18 | hypermobility of coccyx | KG + DL |
| 19 | rheumatoid vasculitis | KG + DL |
| 20 | echinococcus granulosus infectious disease | KG + DL |
| 21 | Kummell disease | KG + DL |
| 22 | osteoarthritis susceptibility | KG + DL |
| 23 | polyarticular juvenile rheumatoid arthritis | KG + DL |
| 24 | enterobiasis | KG + DL |
| 25 | brachyolmia | KG + DL |
| 26 | brachyolmia-amelogenesis imperfecta syndrome | KG + DL |
| 27 | inflammatory spondylopathy | KG + DL |
| 28 | arthropathy | KG + DL |
| 29 | myosclerosis | KG + DL |
| 30 | Enoplea infectious disease | KG + DL |
| 31 | Trichinella spiralis infectious disease | KG + DL |
| 32 | WHIM syndrome | KG + DL |
| 33 | autosomal recessive familial Mediterranean fever | KG + DL |
| 34 | vertebral disease | KG + DL |
| 35 | systemic mastocytosis | KG + DL |
| 36 | Trichinellosis | KG + DL |
| 37 | alveolar echinococcosis | KG + DL |
| 38 | familial Mediterranean fever, autosomal dominant | KG + DL |
| 39 | juvenile arthritis due to defect in LACC1 | KG + DL |
| 40 | acquired thrombocytopenia | KG + DL |
| 41 | spondyloarthropathy | KG + DL |
| 42 | atrichia with papular lesions | KG + DL |
| 43 | brachydactyly-syndactyly syndrome | KG + DL |
| 44 | cystic echinococcosis | KG + DL |
| 45 | Plasmodium falciparum blood infection level | KG + DL |
| 46 | mixed malaria | KG + DL |
| 47 | Plasmodium falciparum fever episodes quantitative trait locus 1 | KG + DL |
| 48 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 49 | trichinosis | KG + DL |
| 50 | spondyloarthropathy, susceptibility to | KG + DL |
(Showing top 50 of 54 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.